Introducing
Brightiva
The Next Generation of Ketamine Treatment
A path forward for patients. A turnkey platform for prescribers.
What is
Brightiva?
A compounded proprietary three-component formulation, engineered so that each ingredient amplifies the others. Based on more than six years of direct clinical experience and thousands of patients treated, the result is a therapeutic experience that ketamine alone has not been able to achieve.
Ketamine therapy has demonstrated remarkable results for patients with conditions that conventional treatment could not resolve.
Brightiva Was Developed to Take That Further.
New Hope for Patients
This proprietary, patent-pending treatment may provide benefits for a variety of ailments:
- Treatment-Resistant Depression
- Anxiety
- PTSD
- Bipolar Depression
- OCD
- Substance Use Disorders
- Chronic Fatigue
- Fibromyalgia
Patients have described the relief they have found through Brightiva as “life-changing.” And unlike many advanced psychiatric treatments, Brightiva is affordable for most.
Brightiva ships to all U.S. states except Illinois, Mississippi, Hawaii, and Washington D.C.
*Brightiva is a compounded formulation that has not been approved by the FDA for treatment of any medical or psychiatric indications.
What Relief Actually Looks Like
Brightiva is administered as a small dissolvable tablet in your provider’s clinical office under direct observation. It is not available for in-home use. Treatment follows a structured, proprietary protocol. Many patients have reported meaningful improvement within the first two weeks.
The Network Makes it Possible
Brightiva is available exclusively through The Brightiva Network, a credentialed community of licensed prescribers equipped with the clinical protocol, documentation tools, and direct pharmacy fulfillment needed to offer this in-office treatment with confidence and ease.
The People Behind It
Built by Someone Who Watched Patients Struggle. Then Did Something About It.
Brightiva was pioneered by a board-certified psychiatrist with many years of direct ketamine clinical experience and brought to market by one of healthcare’s most accomplished executives.
The Next Step Is Yours
I Am a Prescriber
Find out more about the Network and whether it is right for your practice.
*Brightiva is a compounded formulation that has not been approved by the FDA for treatment of any medical or psychiatric indications.